摘要 |
The invention relates to the use of compounds of general formula AcPhe-Aib-A ib- Aib-x-w-Leu-y-Aib-Hyp-Gln-z-Hyp-Aib-Pro-R, in which R represents Phe-ol or P he- al and w, x, y, and z have the following meaning: a) w represents Gly or Ala ; x represents Aib, and y and z represent Iva; b) w represents Gly; x, y, and z represent Iva; c) w represents Gly; x and z represent Aib, and y represents Iva; d) w represents Gly; x, y, and z represent Aib; or e) w represents Gly; x and y represent Aib, and z represents Iva; or of general formula AcPhe-Iva-G ln- Aib-Ile-Thr-Aib-Leu-Aib-x-Gln-Aib-Hyp-Aib-Pro-Phe-Ser, in which x represents Hyp or Pro, and the physiologically acceptable salts thereof for producing a medicament having a neurological and/or immunosuppressive effect.
|
申请人 |
AVENTIS PHARMA DEUTSCHLAND GMBH |
发明人 |
GRAEFE, UDO;HAERTL, ALBERT;SCHLEGEL, BRIGITTE;SCHIELL, MATTHIAS;WINK, JOACHIM;VERTESY, LASZLO |